Kelly Cushing

Clinical Lecturer

University of Michigan

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Kelly Cushing is a Clinical Lecturer at the University of Michigan, USA. Her research primarily focuses on inflammatory bowel disease and its genetic associations, exploring the interplay between genetics and various health outcomes. Recent publications include studies on the effects of TM6SF2 genotype on hepatic and cardiac events, and the influence of inflammatory bowel disease risk variants on skin cancer incidence.

Articles (12)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (2)

A. Krishna Rao

Associate Professor

University of Michigan

UNITED STATES

View details

Vincent Chen

Assistant Professor

University of Michigan Medical School

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kelly Cushing

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

TM6SF2-rs58542926 Genotype Has Opposing Effects on Incidence of Hepatic and Cardiac Events in a Community Cohort

Genetic insight into the relationship between inflammatory bowel disease and Clostridioides difficile infection

Risk Variants in or Near ZBTB40 AND NFATC1 Increase the Risk of Both IBD and Adverse Bone Health Outcomes Highlighting Common Genetic Underpinnings Across Both Diseases.

An Assessment of Comparative Medication Durability in Inflammatory Bowel Disease Patients With and Without Co-morbid Psoriasis, Rheumatoid Arthritis, and/or Enteropathic Arthritis

Inflammatory Bowel Disease Risk Variants Are Associated with an Increased Risk of Skin Cancer

Efficacy of Ustekinumab in Crohn’s Disease With and Without Concurrent Autoimmune Skin Disease

Hepatic decompensation is accelerated in patients with cirrhosis and alpha-1 antitrypsin Pi∗MZ genotype

Safety and Efficacy of Tumor Necrosis Factor Antagonists in Older Patients With Ulcerative Colitis: Patient-Level Pooled Analysis of Data From Randomized Trials

AXL Is a Potential Target for the Treatment of Intestinal Fibrosis

Assessment of Benefit of Advanced Inflammatory Bowel Disease Training: Challenges and Solutions

Complete histologic normalisation is associated with reduced risk of relapse among patients with ulcerative colitis in complete endoscopic remission

Editorial: histologic normalisation in ulcerative colitis. Authors' reply

Collaborators (2)

A. Krishna Rao

Vincent Chen

Make your next move.